Life Sciences Weekly – Episode 4

Recorded: May 24, 2025

In this episode, we break down the latest headlines shaping the life sciences industry. Tune in for a recap of key FDA approvals, including innovative medical devices and breakthrough drug therapies, as well as the week’s most significant mergers, acquisitions, and funding rounds. We spotlight the FDA’s new, stricter COVID-19 vaccine approval standards—exploring both the support and controversy they’ve generated—and discuss the FTC’s renewed crackdown on improper patent listings that could pave the way for more affordable generics. Plus, hear about major enforcement actions, the evolving regulatory landscape, and what these changes mean for the future of biotech, pharma, and medtech. Whether you’re an industry insider or just curious about the science shaping tomorrow’s healthcare, this episode delivers the insights you need to stay informed.

With your Life Sciences Industry Guide, Matt Davison